Novel synthetic drugs in migraine / Paolo Martelletti, Lars Edvinsson, editors.
2022
RC392 .N68 2022eb
Linked e-resources
Linked Resource
Online Access
Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks
Details
Title
Novel synthetic drugs in migraine / Paolo Martelletti, Lars Edvinsson, editors.
ISBN
9783030953348 (electronic bk.)
3030953343 (electronic bk.)
9783030953331
3030953335
3030953343 (electronic bk.)
9783030953331
3030953335
Published
Cham : Springer, [2022]
Copyright
©2022
Language
English
Description
1 online resource (ix, 109 pages : illustrations).
Item Number
10.1007/978-3-030-95334-8 doi
Call Number
RC392 .N68 2022eb
Dewey Decimal Classification
616.8/4912061
Summary
Published in the series Headache, endorsed by the European Headache Federation, this is the first book on the novel synthetic treatment of migraine with ditans (lasmiditan) and gepants (atogepant, ubrogepant, rimegepant, vazegepant). These drugs will provide additional options for people with migraine put at risk of side effects by other medications or with unsatisfactory response to previous drugs. There is now a sufficient amount of literature published to interest a wide multidisciplinary readership (general physicians, general neurologists, clinical psychologists, neurologists in training, and medical students) facing every day this burdensome disorder in their clinical practice. The book aims therefore at offering an overview of these new drugs for both acute and prophylactic treatments of migraine, covering studies on clinical evidence, tolerability, and the different stages of clinical development.
Access Note
Access limited to authorized users.
Digital File Characteristics
text file PDF
Source of Description
Online resource; title from PDF title page (SpringerLink, viewed May 5, 2022).
Added Author
Martelletti, Paolo, editor.
Edvinsson, Lars, editor.
Edvinsson, Lars, editor.
Series
Headache (Springer (Firm))
Available in Other Form
Print version: 9783030953331
Linked Resources
Online Access
Record Appears in
Online Resources > Ebooks
All Resources
All Resources
Table of Contents
Novel Pharmacological Targets of Migraine: An Overview
Molecular and Cellular Mechanisms of CGRP Antagonists
Atogepant
Ubrogepant
Rimegepant
Zavegepant
Molecular Mechanisms of 5-HT1F Receptor Agonists
Lasmiditan
Update on old and current targets for antimigraine therapies.
Molecular and Cellular Mechanisms of CGRP Antagonists
Atogepant
Ubrogepant
Rimegepant
Zavegepant
Molecular Mechanisms of 5-HT1F Receptor Agonists
Lasmiditan
Update on old and current targets for antimigraine therapies.